Your browser doesn't support javascript.
loading
Lacticaseibacillus paracasei Bacteremia Associated With Probiotic Use in a Child With Hypoganglionosis: Case Report and Literature Review.
Ukai, Kohei; Okamoto, Koh; Ichinose, Akinori; Yoshida, Mariko; Higurashi, Yoshimi; Yoneda, Ryu; Yamamoto, Shuta; Asahara, Takashi.
Afiliação
  • Ukai K; From the Department of Infectious Diseases, The University of Tokyo Hospital.
  • Okamoto K; From the Department of Infectious Diseases, The University of Tokyo Hospital.
  • Ichinose A; Department of Infectious Diseases, Tokyo Medical Dental University Hospital.
  • Yoshida M; Department of Pediatric Surgery, The University of Tokyo Hospital.
  • Higurashi Y; Department of Pediatric Surgery, The University of Tokyo Hospital.
  • Yoneda R; Department of Infection Control and Prevention, The University of Tokyo Hospital, Bunkyo City, Tokyo, Japan.
  • Yamamoto S; Department of Infection Control and Prevention, The University of Tokyo Hospital, Bunkyo City, Tokyo, Japan.
  • Asahara T; Yakult Central Institute, Yakult Honsha Co., Ltd, Kunitachi City, Tokyo, Japan.
Pediatr Infect Dis J ; 2024 Sep 09.
Article em En | MEDLINE | ID: mdl-39259865
ABSTRACT
Probiotics are generally considered safe and used to improve intestinal function. Here, we report a Lacticaseibacillus paracasei bacteremia case in an 8-month-old girl administered probiotics containing L. paracasei after jejunostomy for hypoganglionosis. The patient had persistent bacteremia with L. paracasei and was treated with antimicrobial therapy. The isolate from the blood culture was genetically indistinguishable to the strain contained in probiotics. Bacteremia risk should be considered before probiotic use in patients with underlying compromised immune systems or intestinal integrity.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article